Maria Vittoria Cossu

9PUBLICATIONS
40CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Behavioural epidemiologyMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 16, 2026
High frequency of isavuconazole use over voriconazole for chronic pulmonary aspergillosis: a retrospective observational study on tolerability and therapeutic drug monitoring.

|Sep 10, 2026
Long-acting cabotegravir and rilpivirine in people with HIV and cancer: Virological eligibility and DDI considerations.

|Jul 10, 2026
Extreme Cardiovascular Risk and LDL-C Target Achievement in People With HIV.

|Jul 08, 2026
Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV on Any Antiretroviral Therapy Regimen: The Retrospective ESSENTIAL Study.

|Jul 06, 2026
A real-world implementation study of a TDM-guided dalbavancin model for bone and joint infections (101 Dalbatians).

|Feb 26, 2026
Pneumococcal Vaccination Uptake Among People with HIV Following the Implementation of an On-Site Vaccination Service in an Italian Specialist Out-Patient Clinic.

Anna Lisa Ridolfo, Maria Vittoria Cossu, Letizia Oreni

Pageof 2

Frequent Collaborators

6 joint publications

Andrea Gori

4 joint publications

Andrea Giacomelli

4 joint publications

Cristina Gervasoni

3 joint publications

Spinello Antinori